The ocular effects of spitting cobras: I. The ringhals cobra (Hemachatus haemachatus) Venom-Induced corneal opacification syndrome

References

• Rose W. The Reptiles and Amphibians of South Africa. Maskew Miller, Cape Town 1950
   Google Scholar
• Chapman D S. The symptomatology, pathology and treatment of the bites of venomous snakes of Central and Southern Africa. Venomous Animals and their Venoms, Vol I, Venomous Vertebrates, W Bucherl, E E Buckley, V Deulofeu. Academic Press, New York 1968; 463
   Google Scholar
• Gomes B. External ophthalmoplegia from snake poison. Ophthalmology 1943; 3: 187–194
   Google Scholar
• Strover H M. Observations on two cases of snakebite by Naja nigricollis SS mossambica. Cent Afr J Med 1973; 19: 12–13
   PubMedGoogle Scholar
• Christensen P A. South African Snake Venoms and Antivenins. S Afr Inst Med Res, Johannesburg 1955
   Google Scholar
• Gilkes M J. Snake venom conjunctivitis. Br J Ophthal 1959; 43: 638–639
   PubMedGoogle Scholar
• Sinha A K. Cobra venom conjunctivitis. Lancet 1972; 1: 1026
   PubMed Web of Science ®Google Scholar
• Warrell D A, Ormerod L D. Snake venom ophthalmia and blindness caused by the spitting cobra (Naja nigricollis) in Nigeria. Am J Trop Med Hyg 1976; 25: 525–529
   PubMed Web of Science ®Google Scholar
• Grüntzig J. Die Spei-Kobra-Opthalmie (Naja nigricollis). Klin Monatsbl Augenheilkd 1984; 185: 527–530
   PubMed Web of Science ®Google Scholar
• Grüntzig J, Lenz W, Mebs D. Experimental studies on the spitting cobra ophthalmia (Naja nigricollis). Graefes Arch Clin Exp Opthalmol 1985; 223: 196–201
   PubMed Web of Science ®Google Scholar
• Ismail M, Ellison A C. Ocular effects of the venom from the spitting cobra (Naja nigricollis). J Toxicol Clin Toxicol 1986; 24: 183–202
   PubMed Web of Science ®Google Scholar
• Ismail Ghazal M. A, Abdel-Rahman A A, El-Asmar M F. Immunological studies with scorpion (Androctonus amoreuxi, Aud & Sav) venom. Toxicon 1975; 13: 405–408
   PubMed Web of Science ®Google Scholar
• Ismail M, Shibl A M, Morad A M, Abdullah M E. Pharmacokinetics of 125I-labelled antivenin to the venom from the scorpion Androctontis amoreuxi. Toxicon 1983; 21: 47–56
   PubMed Web of Science ®Google Scholar
• Ouchterlony O. In vitro method for testing the toxin producing capacity of diphtheria bacteria. Acta Path Microbiol Scand 1948; 25: 186–191
   PubMedGoogle Scholar
• Hogan M J, Zimmerman L E. Opthalmic Pathology. An Atlas and Text Book, 2nd ed. Saunders, Philadelphia and London 1962; 294
   Google Scholar
• Ismail M, Al-Bekairi A M, El-Bedaiwy A M, Abd-El Salam M A. The ocular effects of spitting cobras: II. Evidence that cardiotoxins are responsible for the corneal opacification syndrome. J Toxicol Clin Toxicol 1993; 31: 45–62
   PubMed Web of Science ®Google Scholar
• Braganca B M, Quastel J H. Action of snake venom on acetylcholine synthesis in the brain. Nature 1952; 169: 695–697
   PubMed Web of Science ®Google Scholar
• Hogberg B, Uvnas B. Further observation on the disruption of rat mesentery mast cells caused by compound 48/80, antigen-antibody reaction, lecithinase and decylamine. Acta Physiol Scand 1960; 48: 133–145
   PubMedGoogle Scholar
• Mohamed A H, el-Serougi M S, Hamed R M. Effects of Naja nigricollis on histamine of blood and tissues. Toxicon 1971; 9: 169–172
   PubMed Web of Science ®Google Scholar
• Osman O H, Ismail M, Karrar M A. Acetylcholine release from the nerve terminals of the guinea pig ileum by Naja venoms. Toxicon 1976; 14: 127–132
   PubMed Web of Science ®Google Scholar
• Osman O H, Elkhawad A O, Ismail M. Hypothermic effect in rats of Naja nigricollis venom: Role of acetylcholine. Toxicon 1977; 15: 75–80
   PubMed Web of Science ®Google Scholar
• Bonta I L, Vargaftig B B, Bohm G M. Snake venoms as an experimental tool to induce and study models of microvessel damage. Handbook of Experimental Pharmacology, Vol 52, Snake Venoms, C Y Lee. Springer Verlag, New York 1979; 629
   Google Scholar
• Mebs D. A comparative study of enzyme activities in snake venoms. Int J Biochem 1970; 1: 335–342
   Google Scholar
• Ellison A C, Poirier R. Therapeutic effect of heparin on Pseudomonas-induced corneal ulceration. Am J Ophthalmol 1976; 82: 619–627
   PubMed Web of Science ®Google Scholar
• Brown S I, Hook C W. Treatment of corneal destruction with collagenase inhibitors. Trans Am Acad Ophthalmol Otolaryngol 1971; 75: 1199–1207
   PubMedGoogle Scholar
• Berman M B, Manabe R. Corneal collagenase: Evidence for zinc metalloenzymes. Ann Ophthalmol 1973; 5: 1193–1209
   PubMedGoogle Scholar
• Zeller F A. Enzymes as essential components of toxins. The Enzymes, J B Summer, K Myrback. Academic Press, New York 1951; Vol I: 1010, Part II
   Google Scholar
• Sarkar N K, Devi A. Enzymes in snake venoms. Venomous Animals and their Venoms, Vol I, Venomous Vertebrates, W Bucherl, E E Buckley, V Deulofeu. Academic Press, New York 1968; 167
   Google Scholar
• Hokama Y, Iwanaga S, Tatsuki T, Suzuki T. Snake venom proteinase inhibitors: Isolation of five polypeptide inhibitors from the venoms of Hemachatus haemachatus (Ringhals cobra) and Naja nivae (Cape cobra) and the complete amino acid sequences of two of them. J Biochem 1976; 79: 559–578
   PubMed Web of Science ®Google Scholar
• Iwanaga S, Suzuki T. Enzymes in snake venoms. Handbook of Experimental Pharmacology, Vol 52, Snake Venoms, C Y Lee. Springer Verlag, New York 1979; 61
   Google Scholar
• Sande M A, Mandell G L. Antimicrobial agents. The Pharmacological Basis of Therapeutics, 7th ed., A G Gilman, T W Rall, A S Nies, P Taylor. Pergamon Press, New York 1990; 1117
   Google Scholar
• Mitscher L A. The Chemistry of the Tetracycline Antibiotics. Marcel Dekker, New York 1978
   Google Scholar